Provides one-stop solutions for the entire process of biopharmaceutical business from R&D to clinical trials, regulatory affairs, production and distribution.
212 million people speak the Portuguese language in Brazil, do you want to speak with them?
-29.63835
-51.0043
Africa
More than 2000 companies already use Weglot on the African continent, and these numbers are only growing.
7.401962
3.917313
Magazine
Bispecific antibodies : the next generation of immunotherapy
In general, antibodies specifically react and bind to a single antigen. Antibodies with this characteristic are referred to as “monoclonal antibodies.”Recently, there has been growing interest in ‘bispecific antibodies,’ which complement the characteristics of monoclonal antibodies to enhance the efficacy of antibody-based therapies.
Bispecific antibodies : the next generation of immunotherapy
In general, antibodies specifically react and bind to a single antigen. Antibodies with this characteristic are referred to as “monoclonal antibodies.”Recently, there has been growing interest in ‘bispecific antibodies,’ which complement the characteristics of monoclonal antibodies to enhance the efficacy of antibody-based therapies.
Bispecific antibodies : the next generation of immunotherapy
In general, antibodies specifically react and bind to a single antigen. Antibodies with this characteristic are referred to as “monoclonal antibodies.”Recently, there has been growing interest in ‘bispecific antibodies,’ which complement the characteristics of monoclonal antibodies to enhance the efficacy of antibody-based therapies.
